Arvest Investments’s AbbVie ABBV Stock Holding History

Arvest Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Sell	6,201 -729	-11%	-$157K	0.19%	77
2026 Q1	$1.51M	Sell	6,930 -84	-1%	-$18.6K	0.21%	75
2025 Q4	$1.6M	Sell	7,014 -109	-2%	-$24.8K	0.23%	70
2025 Q3	$1.65M	Sell	7,123 -3,188	-31%	-$649K	0.24%	76
2025 Q2	$1.91M	Sell	10,311 -38	-0.4%	-$7.06K	0.29%	65
2025 Q1	$2.17M	Sell	10,349 -139	-1%	-$27K	0.34%	58
2024 Q4	$1.86M	Sell	10,488 -756	-7%	-$139K	0.3%	71
2024 Q3	$2.22M	Buy	11,244 +114	+1%	+$21.3K	0.34%	60
2024 Q2	$1.91M	Sell	11,130 -70	-0.6%	-$11.6K	0.31%	76
2024 Q1	$2.04M	Sell	11,200 -233	-2%	-$40.2K	0.32%	66
2023 Q4	$1.77M	Buy	+11,433	New	+$1.67M	0.29%	80

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Arvest Investments's ABBV Position: Q2 2026 in Review

Arvest Investments reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $157K and leaving 6,201 shares worth $1.56M. The position accounts for 0.19% of the portfolio, ranked #77.

Arvest Investments first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.22M in Q3 2024. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Arvest Investments held 6,201 shares of AbbVie worth $1.56M as of Q2 2026.
Arvest Investments sold 729 AbbVie shares in Q2 2026, an estimated $157K.
AbbVie made up 0.19% of Arvest Investments's portfolio in Q2 2026, its #77 holding.
Arvest Investments first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Arvest Investments's AbbVie position peaked at $2.22M in Q3 2024.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Arvest Investments's 13F filing for Q2 2026, filed 17 Jul 2026.